Lessons from a Mouse Model Characterizing Features of Vascular Cognitive Impairment with White Matter Changes
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
With the demographic shift in age in advanced countries inexorably set to progress in the 21st century, dementia will become one of the most important health problems worldwide. Vascular cognitive impairment is the second most common type of dementia after Alzheimer's disease and is frequently responsible for the cognitive decline of the elderly. It is characterized by cerebrovascular white matter changes; thus, in order to investigate the underlying mechanisms involved in white matter changes, a mouse model of chronic cerebral hypoperfusion has been developed, which involves the narrowing of the bilateral common carotid arteries with newly designed microcoils. The purpose of this paper is to provide a comprehensive summary of the achievements made with the model that shows good reproducibility of the white matter changes characterized by blood-brain barrier disruption, glial activation, oxidative stress, and oligodendrocyte loss following chronic cerebral hypoperfusion. Detailed characterization of this model may help to decipher the substrates associated with impaired memory and move toward a more integrated therapy of vascular cognitive impairment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mnemonic coding of visual space in the monkey's dorsolateral prefrontal cortex
Funahashi, S., Bruce, C. J., & Goldman-Rakic, P. S. (1989) · Journal of Neurophysiology · doi:10.1152/jn.1989.61.2.331 · Cited by 2,685 · cited 1×
“In previous studies, working memory deficits have been related either to the hippocampus or frontal subcortical circuits in the rodent [13, 46] and likely primates [47, 48].”
BackgroundAdrenomedullin: A Novel Hypotensive Peptide Isolated from Human Pheochromocytoma
Kitamura, K., Kangawa, K., Kawamoto, M., Ichiki, Y., Nakamura, S., Matsuo, H., & Eto, T. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1451 · Cited by 2,192
Pathogenesis of Leukoaraiosis: A Review
Pantoni, L., & Garcia, J. H. (1997) · Stroke · doi:10.1161/01.str.28.3.652 · Cited by 1,225 · cited 1×
“…Shogoin, Sakyo, Kyoto 606-8507, Japan 2 Department of Neurology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie 514-8507, Japan Correspondence should be addressed to Masafumi Ihara, ihara@kuhp.kyoto-u.ac.jp Received 26 March 2011; Accepted 26 July 2011 Academic…”
BackgroundGlial regulation of the cerebral microvasculature
Iadecola, C., & Nedergaard, M. (2007) · Nature Neuroscience · doi:10.1038/nn2003 · Cited by 1,153 · cited 1×
“sis and function [83], angio-/arteriogenesis and inhibition of oxidative damage in the cerebral endothelial cells”
BackgroundSubcortical ischaemic vascular dementia
Román, G. C., Erkinjuntti, T., Wallin, A., Pantoni, L., & Chui, H. C. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00190-4 · Cited by 1,067
Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s disease
Bartzokis, G. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.03.001 · Cited by 968 · cited 1×
“Given that oligodendrocytes are highly susceptible to Aβ toxicity [62], the results may further provide evidence linking chronic hypoperfusion with neurodegeneration.”
BackgroundWhite Matter Lesions and Glial Activation in a Novel Mouse Model of Chronic Cerebral Hypoperfusion
Shibata, M., Ohtani, R., Ihara, M., & Tomimoto, H. (2004) · Stroke · doi:10.1161/01.str.0000143725.19053.60 · Cited by 583 · cited 10×
“until 30 days, compared with the sham-operated controls [10].”
BackgroundMethodResultInfluentialSelf-citationLi, N.-C., Lee, A., Whitmer, R. A., Kivipelto, M., Lawler, E., Kazis, L. E., & Wolozin, B. (2010) · BMJ · doi:10.1136/bmj.b5465 · Cited by 486
Do in vivo Experimental Models Reflect Human Cerebral Small Vessel Disease? a Systematic Review
Hainsworth, A. H., & Markus, H. S. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2008.91 · Cited by 240
Ueno, M., Tomimoto, H., Akiguchi, I., Wakita, H., & Sakamoto, H. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200201000-00012 · Cited by 147 · cited 1×
“report on a rat model of chronic cerebral hypoperfusion [38] and further indicates a vulnerability of the BBB in this area.”
BackgroundSelf-citationIhara, M., Tomimoto, H., Kinoshita, M., Oh, J., Noda, M., Wakita, H., Akiguchi, I., & Shibasaki, H. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200107000-00008 · Cited by 115 · cited 1×
“AG3340 administration has been shown to decrease IgM-immunoreactive glial cell density in the vicinity of the microvessels in the corpus callosum, suggesting it helps restore BBB integrity [21, 37].”
BackgroundSelf-citationChronic cerebral hypoperfusion accelerates amyloid β deposition in APPSwInd transgenic mice
Kitaguchi, H., Tomimoto, H., Ihara, M., Shibata, M., Uemura, K., Kalaria, R. N., Kihara, T., Asada-Utsugi, M., Kinoshita, A., & Takahashi, R. (2009) · Brain Research · doi:10.1016/j.brainres.2009.07.078 · Cited by 108
Self-citationBlood-brain barrier dysfunction in Binswanger’s disease; an immunohistochemical study
Akiguchi, I., Tomimoto, H., Suenaga, T., Wakita, H., & Budka, H. (1998) · Acta Neuropathologica · doi:10.1007/s004010050768 · Cited by 104
Self-citationMaki, T., Ihara, M., Fujita, Y., Nambu, T., Miyashita, K., Yamada, M., Washida, K., Nishio, K., Ito, H., Harada, H., et al. (2011) · Stroke · doi:10.1161/strokeaha.110.603399 · Cited by 88 · cited 2×
“arm radial maze test [43].”
MethodSelf-citationRichard, E., Gouw, A. A., Scheltens, P., & van Gool, W. A. (2010) · Stroke · doi:10.1161/strokeaha.109.571281 · Cited by 82 · cited 1×
“WM lesions in AD progress relatively slowly if a multicomponent intervention is given to reduce vascular risk factors [55], suggesting that ischemic changes underlie the WM lesions in AD.”
Background
Research works printed but not linked: 69
- 10.1161/01.STR.0000122624.32167.e0 · DOI
- 10.1007/s00401-006-0185-2 · DOI · Paper page
- 1995, Stroke, 26, 1293, 10.1161/01.STR.26.7.1293 · DOI · Paper page
- 10.1002/ana.410280313 · DOI · Paper page
- 10.1017/S104161020300930X · DOI
- 1990, Stroke, 21, 1694, 10.1161/01.STR.21.12.1694 · DOI · Paper page
- 10.1007/s004010050114 · doi:10.1007/s004010050114
- 1990, Stroke, 21, 1205, 10.1161/01.STR.21.8.1205 · DOI · Paper page
- 10.1016/j.brainresrev.2007.01.003 · DOI · Paper page
- 10.1016/S0166-4328(02)00090-6 · DOI
- 2005, Pharmacology Biochemistry and Behavior, 81, 616, 10.1016/j.pbb.2005.05.004 · DOI
- 10.1016/j.expneurol.2007.12.005 · DOI · Paper page
- 1999, Stroke, 30, 2752, 10.1161/01.STR.30.12.2752 · DOI · Paper page
- 10.1016/0006-8993(94)01436-L · DOI · Paper page
- 10.1111/j.1471-4159.2010.06958.x · DOI · Paper page
- 1992, Acta Neuropathologica, 84, 437
- 10.1161/STROKEAHA.107.490151 · DOI · Paper page
- 10.1161/01.STR.0000244808.17972.55 · DOI · Paper page
- 10.1002/jnr.21925 · DOI · Paper page
- 10.1016/j.jns.2009.05.010 · DOI
- 10.2165/11584760-000000000-00000 · DOI
- 10.1016/S0006-8993(01)02801-3 · DOI
- 10.1161/STROKEAHA.110.581686 · DOI · Paper page
- 10.1016/j.neuroimage.2006.12.040 · DOI · Paper page
- 1997, Stroke, 28, 1423, 10.1161/01.STR.28.7.1423 · DOI · Paper page
- 10.1016/S0006-8993(98)00126-7 · DOI
- 1995, Stroke, 26, 1415, 10.1161/01.STR.26.8.1415 · DOI · Paper page
- 10.1016/0006-8993(92)90681-X · DOI · Paper page
- 1995, Stroke, 26, 2120, 10.1161/01.STR.26.11.2120 · DOI · Paper page
- 10.1083/jcb.125.5.1165 · DOI · Paper page
- 10.1016/0304-3940(95)12173-0 · DOI · Paper page
- 10.1002/jnr.22257 · DOI
- 2001, Stroke, 32, 1162, 10.1161/01.STR.32.5.1162 · DOI · Paper page
- 10.1002/ana.20447 · DOI
- 10.1161/STROKEAHA.110.583948 · DOI · Paper page
- 10.1016/j.neurobiolaging.2010.09.005 · DOI
- 10.1016/j.neurobiolaging.2010.11.009 · DOI
- 10.1038/jcbfm.2008.121 · DOI · Paper page
- 10.1016/S0306-4522(97)00037-7 · DOI · Paper page
- 10.1162/089892906775990552 · DOI · Paper page
- 10.1161/01.STR.0000126041.99024.86 · DOI · Paper page
- 2004, Neurology, 62, 310, 10.1212/01.WNL.0000103289.03648.AD · DOI · Paper page
- 1990, Journal of Neurology Neurosurgery and Psychiatry, 53, 161, 10.1136/jnnp.53.2.161 · DOI · Paper page
- 10.1016/S0022-510X(02)00256-3 · DOI · Paper page
- 2003, Neuropathology and Applied Neurobiology, 29, 159, 10.1046/j.1365-2990.2003.00456.x · DOI · Paper page
- 2003, Neurology, 61, 950, 10.1212/01.WNL.0000086375.33512.53 · DOI · Paper page
- 10.1007/s00401-009-0635-8 · DOI · Paper page
- 10.1097/WNR.0b013e32823ed031 · DOI
- 10.1016/S0197-4580(00)00125-1 · DOI · Paper page
- 1999, Alzheimer Disease and Associated Disorders, 13, S115
- 2011, PLoS ONE, 6
- 2003, Current Topics in Medicinal Chemistry, 3, 413, 10.2174/1568026033392200 · DOI
- 1999, Journal of Neuroscience, 19, 9192, 10.1523/JNEUROSCI.19-21-09192.1999 · DOI · Paper page
- 10.1016/0006-8993(95)01153-6 · DOI · Paper page
- 10.1161/01.STR.0000060204.67672.8B · DOI · Paper page
- 10.1001/archinte.163.9.1069 · DOI · Paper page
- 10.1212/01.wnl.0000311447.85948.78 · DOI · Paper page
- 2010, Biochemical and Biophysical Research Communications, 404, 434
- 10.1161/01.HYP.0000123072.34629.57 · DOI · Paper page
- 10.1161/01.ATV.0000184759.91369.f8 · DOI · Paper page
- 10.1038/jcbfm.2009.92 · DOI
- 10.1016/j.brainresbull.2010.11.005 · doi:10.1016/j.brainresbull.2010.11.005
- 10.1161/STROKEAHA.108.533141 · DOI · Paper page
- 10.1161/CIRCULATIONAHA.105.589937 · DOI
- 10.1161/STROKEAHA.110.596379 · DOI · Paper page
- 10.1161/STROKEAHA.108.533117 · DOI · Paper page
- 10.1002/jnr.21617 · DOI
- 10.1523/JNEUROSCI.0035-09.2009 · DOI · Paper page
- 10.1248/bpb.32.1639 · DOI
Cited by
The Pathobiology of Vascular Dementia
Iadecola, C. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.008 · Cited by 1,857
“These models have demonstrated that counteracting some of the pathogenic factors, including chronic ischemia, inflammation, and oxidative stress, reduce white matter damage and/or behavioral deficits (Dong et al., 2011; Ihara and Tomimoto, 2011; Maki et al., 2011).”
Models and mechanisms of vascular dementia
Venkat, P., Chopp, M., & Chen, J. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.05.006 · Cited by 341
Maki, T., Liang, A. C., Miyamoto, N., Lo, E. H., & Arai, K. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00275 · Cited by 99
“In this regard, rat and mouse models of prolonged cerebral hypoperfusion have been developed and widely used (Farkas et al., 2007; Ihara and Tomimoto, 2011).”
BackgroundSigfridsson, E., Marangoni, M., Johnson, J. A., Hardingham, G. E., Fowler, J. H., & Horsburgh, K. (2018) · Scientific Reports · doi:10.1038/s41598-018-30675-4 · Cited by 41
Distinct Impacts of Fullerene on Cognitive Functions of Dementia vs. Non-dementia Mice
Wu, Y., Wang, R., Wang, Y., Gao, J., Feng, L., & Yang, Z. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00075-1 · Cited by 9
Metadata
- Authors
- Ihara, M., & Tomimoto, H.
- Venue
- Journal of Aging Research
- Publisher
- Hindawi Limited
- Published
- 2011
- Volume
- 2011
- Pages
- 1-11
- ISSN
- 2090-2204 (ISSN-L)
- 2090-2212
- OpenAlex
- W2049884959
- Cited by
- 73
- References
- 15
- FWCI
- 1.07
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.